Yogo Naoyuki

• 2019 - 2022 肺癌バイオマーカーの多項目分析のためのマイクロ免疫診断チップ開発
• 2014 - 2017 Identification of driver genes in lung cancer through a semi-genome wide shRNA library screen based on anoikis resistance phenotype
• 2014 - 2016 Development of a novel therapeutic strategy targeting genes contributing to forming cluster in EGFR mutated lung cancer

• Takafumi Yamamoto, Takanori Ito, Tetsunari Hase, Masatoshi Ishigami, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hirofumi Shibata, et al. Immune-related liver injury is a poor prognostic factor in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Cancer investigation. 2021. 40. 2. 1-31
• Naoya Ozawa, Tetsunari Hase, Takahiro Hatta, Atsunobu Sagara, Kazuya Ichikawa, Masayuki Miyazaki, Naoyuki Yogo, Masahiko Ando, Naozumi Hashimoto, Kiyofumi Yamada, et al. Comparing incidences of infusion site reactions between brand-name and generic vinorelbine in patients with non-small cell lung cancer. British journal of clinical pharmacology. 2021. 87. 3. 1318-1326
• Tetsunari Hase, Masayuki Miyazaki, Kazuya Ichikawa, Naoyuki Yogo, Naoya Ozawa, Takahiro Hatta, Masahiko Ando, Mitsuo Sato, Masashi Kondo, Kiyofumi Yamada, et al. Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study. International journal of clinical oncology. 2020. 25. 11. 1928-1935
• Naoyuki Yogo, Tetsunari Hase, Toshihiro Kasama, Keine Nishiyama, Naoya Ozawa, Takahiro Hatta, Hirofumi Shibata, Mitsuo Sato, Kazuki Komeda, Nozomi Kawabe, et al. Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients. PloS one. 2020. 15. 11. e0241422
• Sato Mitsuo, Tanaka Ichidai, Goto Daiki, Kato Toshio, Kakumu Tomohiko, Miyazawa Ayako, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Sekido Yoshitaka, et al. The Subunit eIF2 ss of Translation- Initiation Factor EIF2 Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer. CANCER SCIENCE. 2018. 109. 1181

ｍore...

• 與語直之, 長谷哲成, 笠間敏博, 八田貴広, 小沢直也, 佐藤光夫, 馬場嘉信, 長谷川好規. 肺癌における迅速なEGFR・ALK・ROS1遺伝子検査を目的としたマイクロ免疫診断チップ開発. 日本内科学会雑誌. 2019. 108. Suppl. 283-283
• 田中 一大, 佐藤 光夫, 加藤 俊夫, 後藤 大輝, 各務 智彦, 宮沢 亜矢子, 與語 直之, 長谷 哲成, 森瀬 昌宏, 関戸 好孝, et al. eIF2b is a Potential Therapeutic Target for Non-small Cell Lung Cancer(和訳中). 肺癌. 2018. 58. 6. 669-669
• 佐藤 光夫, 田中 一大, 後藤 大輝, 加藤 俊夫, 各務 智彦, 宮沢 亜矢子, 與語 直之, 長谷 哲成, 森瀬 昌弘, 関戸 好孝, et al. 非小細胞肺癌に対する新規治療標的としての転写開始因子EIF2サブユニットEIF2β(The Subunit eIF2β of Translation-Initiation Factor EIF2 Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer). 日本癌学会総会記事. 2018. 77回. 1819-1819
• 與語 直之, 長谷 哲成, 小沢 直也, 佐藤 光夫, 長谷川 好規. 肺癌体細胞変異の免疫学的診断システムの開発 組織検体におけるEGFR遺伝子変異の検出. 気管支学. 2018. 40. Suppl. S224-S224
• 中股征哉, 笠間敏博, 笠間敏博, 長谷哲成, 與語直之, 與語直之, 小沢直也, 真栄城正寿, 石田晃彦, 佐藤光夫, et al. イムノウォールデバイスの開発と遺伝子変異たんぱく質の検出. 化学系学協会北海道支部冬季研究発表会(Web). 2018. 2018. ROMBUNNO.2C18 (WEB ONLY)

ｍore...

• 分析デバイス

THE JAPANESE ASSOCIATION FOR INFECTIOUS DISEASES ,  THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY ,  JAPANESE SOCIETY OF ALLERGOLOGY ,  THE JAPAN LUNG CANCER SOCIETY ,  THE JAPANESE RESPIRATORY SOCIETY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  日本医師会